Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
532.74
+2.79 (0.53%)
Dec 3, 2024, 1:44 PM EST - Market open
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laboratory Products | 22.94B | 22.93B | 23.00B | 23.04B | 23.27B | 23.13B | 22.83B | 22.51B | ||||||||||||||||||||
| Laboratory Products Growth | -1.41% | -0.86% | 0.74% | 2.35% | 12.09% | 23.93% | 36.66% | 51.47% | ||||||||||||||||||||
| Life Sciences Solutions | 9.50B | 9.54B | 9.65B | 9.98B | 10.55B | 11.08B | 11.91B | 13.53B | ||||||||||||||||||||
| Life Sciences Solutions Growth | -10.02% | -13.90% | -18.99% | -26.27% | -27.89% | -28.00% | -23.93% | -13.43% | ||||||||||||||||||||
| Analytical Instruments | 7.31B | 7.26B | 7.23B | 7.26B | 7.10B | 6.97B | 6.83B | 6.62B | ||||||||||||||||||||
| Analytical Instruments Growth | 2.96% | 4.15% | 5.83% | 9.65% | 9.78% | 10.20% | 10.15% | 9.14% | ||||||||||||||||||||
| Speciality Diagnostics | 4.46B | 4.41B | 4.41B | 4.41B | 4.42B | 4.40B | 4.39B | 4.76B | ||||||||||||||||||||
| Speciality Diagnostics Growth | 1.02% | 0.39% | 0.39% | -7.52% | -13.35% | -18.45% | -20.58% | -15.83% | ||||||||||||||||||||
| Eliminations | -1.84B | -1.80B | -1.79B | -1.83B | -1.92B | -2.05B | -2.16B | -2.51B |
Operating Income by Segment
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Life Sciences Solutions | 3.45B | 3.47B | 3.42B | 3.42B | 3.57B | 3.73B | 4.24B | 5.58B | ||||||||||||||||||||
| Life Sciences Solutions Growth | -3.37% | -6.97% | -19.28% | -38.73% | -45.50% | -49.04% | -45.01% | -28.59% | ||||||||||||||||||||
| Laboratory Products | 3.07B | 3.23B | 3.31B | 3.36B | 3.39B | 3.18B | 3.05B | 2.87B | ||||||||||||||||||||
| Laboratory Products Growth | -9.56% | 1.64% | 8.67% | 16.92% | 34.52% | 45.91% | 57.53% | 55.75% | ||||||||||||||||||||
| Analytical Instruments | 1.88B | 1.89B | 1.89B | 1.91B | 1.80B | 1.72B | 1.63B | 1.51B | ||||||||||||||||||||
| Analytical Instruments Growth | 4.45% | 10.44% | 15.98% | 26.61% | 27.27% | 32.95% | 32.71% | 25.90% | ||||||||||||||||||||
| Speciality Diagnostics | 1.15B | 1.14B | 1.14B | 1.12B | 1.07B | 1.01B | 951.00M | 1.02B | ||||||||||||||||||||
| Speciality Diagnostics Growth | 7.68% | 13.43% | 19.66% | 9.77% | -4.04% | -16.46% | -21.08% | -20.00% |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative | 6.83B | 6.67B | 6.65B | 6.57B | 6.73B | 6.90B | 6.97B | 7.13B | ||||||||||||||||||||
| Selling, General, and Administrative Growth | 1.43% | -3.33% | -4.47% | -7.83% | -7.12% | -4.63% | -2.00% | 4.17% | ||||||||||||||||||||
| Amortization of Intangibles | 2.08B | 2.21B | 2.28B | 2.34B | 2.37B | 2.38B | 2.39B | 2.40B | ||||||||||||||||||||
| Amortization of Intangibles Growth | -12.25% | -6.98% | -4.56% | -2.38% | 4.32% | 13.30% | 22.86% | 36.00% | ||||||||||||||||||||
| Research and Development | 1.34B | 1.32B | 1.32B | 1.34B | 1.40B | 1.43B | 1.45B | 1.47B | ||||||||||||||||||||
| Research and Development Growth | -4.14% | -8.16% | -9.02% | -9.11% | -4.82% | -2.65% | 0.21% | 4.62% | ||||||||||||||||||||
| Restructuring and Other | 231.00M | 270.00M | 376.00M | 459.00M | 434.00M | 383.00M | 224.00M | 114.00M | ||||||||||||||||||||
| Restructuring and Other Growth | -46.77% | -29.50% | 67.86% | 302.63% | 313.33% | 325.56% | 21.08% | -42.13% |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.